Q3 2022 |
186 |
$1.8B |
+$270M |
-$109M |
+$161M |
ROP, CSL, DOV, MSFT, AAPL
|
13F-HR |
10/26/2022, 09:49 AM |
Q2 2022 |
169 |
$1.78B |
+$145M |
-$173M |
-$27.6M |
ROP, CSL, DOV, MSFT, AAPL
|
13F-HR |
7/19/2022, 06:40 PM |
Q1 2022 |
189 |
$2.23B |
+$261M |
-$490M |
-$229M |
ROP, DOV, CSL, MSFT, AAPL
|
13F-HR |
5/5/2022, 12:55 PM |
Q4 2021 |
190 |
$2.71B |
+$240M |
-$582M |
-$343M |
ROP, DOV, MSFT, CSL, AMZN
|
13F-HR |
2/7/2022, 02:15 PM |
Q3 2021 |
178 |
$2.72B |
+$217M |
-$205M |
+$12M |
ROP, DOV, AMZN, MSFT, CSL
|
13F-HR |
11/2/2021, 12:37 PM |
Q2 2021 |
176 |
$2.74B |
+$339M |
-$274M |
+$64.6M |
ROP, DOV, MSFT, CSL, AAPL
|
13F-HR |
8/10/2021, 01:45 PM |
Q1 2021 |
153 |
$2.42B |
+$270M |
-$362M |
-$92.2M |
ROP, DOV, CSL, MSFT, AAPL
|
13F-HR |
5/4/2021, 10:49 AM |
Q4 2020 |
145 |
$2.45B |
+$162M |
-$164M |
-$1.96M |
ROP, DOV, CSL, AMZN, ADBE
|
13F-HR |
1/27/2021, 11:52 AM |
Q3 2020 |
134 |
$2.24B |
+$289M |
-$205M |
+$83.8M |
ROP, DOV, ADBE, AMZN, MSFT
|
13F-HR |
11/3/2020, 09:14 AM |
Q2 2020 |
125 |
$2.01B |
+$241M |
-$131M |
+$109M |
ROP, DOV, CSL, MSFT, ADBE
|
13F-HR |
8/10/2020, 11:50 AM |
Q1 2020 |
117 |
$1.59B |
+$227M |
-$425M |
-$197M |
ROP, DOV, CSL, MSFT, ADBE
|
13F-HR |
5/5/2020, 10:31 AM |
Q4 2019 |
129 |
$2.12B |
+$253M |
-$215M |
+$38.1M |
ROP, DOV, CSL, MSFT, ADBE
|
13F-HR |
2/5/2020, 04:40 PM |
Q3 2019 |
118 |
$1.93B |
+$140M |
-$170M |
-$30.4M |
ROP, CSL, MSFT, DOV, ADBE
|
13F-HR |
11/12/2019, 04:57 PM |
Q2 2019 |
117 |
$1.96B |
+$158M |
-$159M |
-$1.48M |
ROP, CSL, DOV, MSFT, ADBE
|
13F-HR |
8/7/2019, 05:10 PM |
Q1 2019 |
117 |
$1.84B |
+$201M |
-$129M |
+$72.7M |
ROP, CSL, DOV, MSFT, ADBE
|
13F-HR |
5/8/2019, 06:19 PM |
Q4 2018 |
117 |
$1.49B |
+$170M |
-$297M |
-$127M |
ROP, CSL, MSFT, DOV, ADBE
|
13F-HR |
1/29/2019, 04:14 PM |
Q3 2018 |
132 |
$1.9B |
+$140M |
-$138M |
+$1.93M |
ROP, CSL, MSFT, DOV, ADBE
|
13F-HR |
10/30/2018, 02:45 PM |
Q2 2018 |
133 |
$1.76B |
+$238M |
-$181M |
+$57.4M |
ROP, CSL, MSFT, DOV, ADBE
|
13F-HR |
8/2/2018, 05:00 PM |
Q1 2018 |
146 |
$1.66B |
+$275M |
-$197M |
+$78.5M |
ROP, CSL, DOV, MSFT, ADBE
|
13F-HR |
5/2/2018, 04:59 PM |
Q4 2017 |
100 |
$1.59B |
+$205M |
-$120M |
+$85.2M |
ROP, CSL, DOV, MSFT, UNH
|
13F-HR |
2/1/2018, 07:33 PM |
Q3 2017 |
98 |
$1.42B |
+$123M |
-$218M |
-$95.2M |
ROP, CSL, DOV, MSFT, UNH
|
13F-HR |
10/17/2017, 11:32 AM |
Q2 2017 |
92 |
$1.44B |
+$106M |
-$139M |
-$32.9M |
ROP, DOV, CSL, MSFT, UNH
|
13F-HR |
7/26/2017, 10:09 AM |
Q1 2017 |
94 |
$1.44B |
+$171M |
-$95M |
+$75.9M |
ROP, DOV, CSL, ADBE, MSFT
|
13F-HR |
4/13/2017, 11:23 AM |
Q4 2016 |
92 |
$1.31B |
+$200M |
-$202M |
-$1.16M |
ROP, CSL, DOV, MSFT, ADBE
|
13F-HR |
2/2/2017, 10:23 AM |
Q3 2016 |
88 |
$1.27B |
+$107M |
-$176M |
-$68.4M |
ROP, CSL, DOV, META, ADBE
|
13F-HR |
11/7/2016, 02:23 PM |
Q2 2016 |
94 |
$1.29B |
+$115M |
-$107M |
+$8.05M |
ROP, CSL, DOV, GE, META
|
13F-HR |
8/4/2016, 09:59 AM |
Q1 2016 |
92 |
$1.29B |
+$105M |
-$134M |
-$28.8M |
ROP, CSL, DOV, META, GE
|
13F-HR |
5/11/2016, 03:59 PM |
Q4 2015 |
104 |
$1.32B |
+$139M |
-$92.6M |
+$46.1M |
ROP, CSL, DOV, META, DIS
|
13F-HR |
2/4/2016, 10:38 AM |
Q3 2015 |
108 |
$1.18B |
+$91.1M |
-$147M |
-$55.6M |
ROP, CSL, DOV, DIS, CAVM
|
13F-HR |
10/22/2015, 11:58 AM |
Q2 2015 |
108 |
$1.38B |
+$146M |
-$146M |
-$23.2K |
ROP, CSL, DOV, MYL, CAVM
|
13F-HR |
7/16/2015, 12:42 PM |
Q1 2015 |
113 |
$1.36B |
+$232M |
-$201M |
+$30.3M |
ROP, CSL, DOV, CAVM, MYL
|
13F-HR |
4/14/2015, 11:29 AM |
Q4 2014 |
117 |
$1.3B |
+$128M |
-$116M |
+$12.5M |
ROP, CSL, DOV, CAVM, ADBE
|
13F-HR |
1/20/2015, 09:39 AM |
Q3 2014 |
118 |
$1.25B |
+$72.8M |
-$89.6M |
-$16.8M |
ROP, CSL, DOV, GILD, ADBE
|
13F-HR |
10/15/2014, 09:43 AM |
Q2 2014 |
120 |
$1.28B |
+$117M |
-$115M |
+$2.05M |
ROP, CSL, DOV, ADBE, PNC
|
13F-HR |
7/17/2014, 09:30 AM |
Q1 2014 |
112 |
$1.26B |
+$134M |
-$128M |
+$6.24M |
ROP, CSL, DOV, GOOGL, PNC
|
13F-HR |
4/15/2014, 12:06 PM |
Q4 2013 |
118 |
$1.26B |
$0 |
$0 |
|
ROP, DOV, CSL, GILD, GOOGL
|
13F-HR |
1/17/2014, 12:41 PM |